FENTANYL Side Effects

6899307-8 | Accidental Overdose, Coma, Fall, Lethargy, Radius Fracture
on Jul 20, 2010 Female patient from GERMANY , 60 years of age, was diagnosed with arthralgia and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: accidental overdose, coma, fall (What is fall?), lethargy, radius fracture. Fentanyl dosage: 75 Mcg/h. Patient was hospitalized.

6895950-0 | Angina Pectoris, Asthenia, Chest Discomfort, Chest Pain, Dyspnoea, Feeling Abnormal, Musculoskeletal Pain, Pain In Extremity, Wheelchair User
Patient was taking Fentanyl (View Usage). Patient had the following side effects: angina pectoris, asthenia, chest discomfort, chest pain (What is chest pain?), dyspnoea, feeling abnormal, musculoskeletal pain, pain in extremity, wheelchair user on Jul 14, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 249.0 lb, was diagnosed with back pain (What is back pain?), fibromyalgia and. Fentanyl dosage: 50 Mcg/hr; 1 Patch Q3d; Tder. During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), NORVASC (View Norvasc Review and Norvasc Label ), PROTONIX (View Protonix Review and Protonix Label ), PAXIL (View Paxil Review and Paxil Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ).

6886140-6 | Somnolence
Adverse event was reported on Jul 16, 2010 by a Male patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), bronchial carcinoma, cardiac failure, coronary artery disease (What is coronary artery disease?), hyperlipidaemia, renal osteodystrophy, nephrogenic anaemia and. Location: GERMANY , 70 years of age, After Fentanyl was administered, patient had the following side effects: somnolence. During the same period patient was treated with TRYASOL CODEIN (View Tryasol Codein Review and Tryasol Codein Label ), SEVREDOL (Max. Alle 8 H) (View Sevredol Review and Sevredol Label ), ATACAND (Tagesschema: 8-0-16) (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCOL (View Locol Review and Locol Label ), NITROSPRAY (View Nitrospray Review and Nitrospray Label ), BONDIOL (View Bondiol Review and Bondiol Label ), NEORECORMON (Samstags) (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6886133-9 | Somnolence
on Jul 16, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with pain (What is pain?), bronchial carcinoma, cardiac failure, coronary artery disease (What is coronary artery disease?), hyperlipidaemia, renal osteodystrophy, nephrogenic anaemia and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: somnolence. Fentanyl dosage: . During the same period patient was treated with TRYASOL CODEIN (View Tryasol Codein Review and Tryasol Codein Label ), SEVREDOL (Max. Alle 8 H) (View Sevredol Review and Sevredol Label ), ATACAND (Tagesschema: 8-0-16) (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCOL (View Locol Review and Locol Label ), NITROSPRAY (View Nitrospray Review and Nitrospray Label ), BONDIOL (View Bondiol Review and Bondiol Label ), NEORECORMON (Samstags) (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.


6886042-5 | Somnolence
on Jul 16, 2010 Male patient from GERMANY , 70 years of age, was diagnosed with pain (What is pain?), bronchial carcinoma, cardiac failure, coronary artery disease (What is coronary artery disease?), hyperlipidaemia, renal osteodystrophy, nephrogenic anaemia and was treated with Fentanyl (View Usage). Patient had the following side effects: somnolence. Fentanyl dosage: . During the same period patient was treated with TRYASOL CODEIN (View Tryasol Codein Review and Tryasol Codein Label ), SEVREDOL (Max. Alle 8 H) (View Sevredol Review and Sevredol Label ), ATACAND (Tagesschema: 8-0-16) (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCOL (View Locol Review and Locol Label ), NITROSPRAY (View Nitrospray Review and Nitrospray Label ), BONDIOL (View Bondiol Review and Bondiol Label ), NEORECORMON (Samstags) (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6882154-0 | Inadequate Analgesia, Product Adhesion Issue, Product Substitution Issue
Patient was taking Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: inadequate analgesia, product adhesion issue, product substitution issue on Jul 27, 2010 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with pain (What is pain?) and. Fentanyl dosage: 1 Patch Transermally Every 72 Hours.

6876710-3 | Serotonin Syndrome
Adverse event was reported on Jul 13, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: 250mcg In Divided Doses Between 8am And 11am) . Location: UNITED STATES , 59 years of age, Patient experienced the following unwanted or unexpected effects: serotonin syndrome. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), INSULIN (View Insulin Review and Insulin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

6876705-X | Serotonin Syndrome
on Jul 13, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Fentanyl (View Usage). Patient had the following side effects: serotonin syndrome. Fentanyl dosage: 250mcg In Divided Doses Between 8am And 11am. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), INSULIN (View Insulin Review and Insulin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

6876704-8 | Serotonin Syndrome
on Jul 13, 2010 Female patient from UNITED STATES , 59 years of age, was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: serotonin syndrome. Fentanyl dosage: 250mcg In Divided Doses Between 8am And 11am. During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), TRAZODONE (View Trazodone Review and Trazodone Label ), INSULIN (View Insulin Review and Insulin Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), OXYCODONE (View Oxycodone Review and Oxycodone Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ). Patient was hospitalized.

6876695-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Serotonin Syndrome
Patient was taking Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, serotonin syndrome on Jul 13, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, was diagnosed with depression (What is depression?), seasonal allergy and. Fentanyl dosage: . During the same period patient was treated with SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

6876694-8 | Serotonin Syndrome
Adverse event was reported on Jul 13, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with depression (What is depression?), seasonal allergy and. Location: UNITED STATES , 46 years of age, Patient had the following side effects: serotonin syndrome. During the same period patient was treated with SERTRALINE HYDROCHLORIDE (View Sertraline Hydrochloride Review and Sertraline Hydrochloride Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), PROPOFOL (View Propofol Review and Propofol Label ). Patient was hospitalized.

6875258-X | Feeling Abnormal, Insomnia, Nausea, Pelvic Pain, Psychomotor Hyperactivity, Terminal Insomnia, Therapeutic Response Delayed
on Jul 13, 2010 Female patient from UNITED STATES , weighting 190.0 lb, was diagnosed with pelvic pain (What is pelvic pain?) and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: feeling abnormal, insomnia, nausea (What is nausea?), pelvic pain (What is pelvic pain?), psychomotor hyperactivity, terminal insomnia, therapeutic response delayed. Fentanyl dosage: . During the same period patient was treated with SOMA (View Soma Review and Soma Label ).

6871832-5 | Blood Cholesterol Increased
on Jul 13, 2010 Female patient from UNITED STATES , weighting 156.0 lb, was diagnosed with back pain (What is back pain?), anxiety (What is anxiety?) and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: blood cholesterol increased. Fentanyl dosage: . During the same period patient was treated with PERCOCET (View Percocet Review and Percocet Label ), XANAX (View Xanax Review and Xanax Label ), LYRICA (View Lyrica Review and Lyrica Label ).

6871095-0 | Infusion Related Reaction, Paralysis
Patient was taking Fentanyl (View Usage). Patient had the following side effects: infusion related reaction, paralysis (What is paralysis?) on Jul 07, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 57 years of age, was diagnosed with procedural pain and. Fentanyl dosage: 2 Ug/ml; Ed. During the same period patient was treated with LEVOBUPIVACAINE (NO PREF. NAME) (1 Mg/ml; Ed) (View Levobupivacaine (no Pref. Name) Review and Levobupivacaine (no Pref. Name) Label ). Patient was hospitalized and became disabled.

6866119-0 | Miosis, Overdose, Pneumonia, Renal Failure Acute, Somnolence, Urinary Retention
Adverse event was reported on Jul 19, 2010 by a Male patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), bronchial carcinoma, cardiac failure, coronary artery disease (What is coronary artery disease?), hyperlipidaemia, renal osteodystrophy, nephrogenic anaemia and. Location: GERMANY , 70 years of age, weighting 180.8 lb, After Fentanyl was administered, patient had the following side effects: miosis, overdose, pneumonia (What is pneumonia?), renal failure acute, somnolence, urinary retention. During the same period patient was treated with TRYASOL CODEIN (View Tryasol Codein Review and Tryasol Codein Label ), SEVREDOL (View Sevredol Review and Sevredol Label ), ATACAND (View Atacand Review and Atacand Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LOCOL (View Locol Review and Locol Label ), NITRO SPRAY (View Nitro Spray Review and Nitro Spray Label ), BONDIOL (View Bondiol Review and Bondiol Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6862247-4 | Blood Magnesium Decreased, Cold Sweat, Dehydration, Diverticulitis, Fatigue, Gastritis, Hyperhidrosis, Hypokalaemia, Hypophagia
on Jul 02, 2010 Female patient from UNITED STATES , 58 years of age, weighting 117.0 lb, was diagnosed with intervertebral disc disorder and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: blood magnesium decreased, cold sweat, dehydration, diverticulitis, fatigue, gastritis, hyperhidrosis, hypokalaemia, hypophagia. Fentanyl dosage: 50 Mcg/hr; 1 Patch Q2d;tder. During the same period patient was treated with FENTANYL 75 (75 Mcg/hr; 1 Patch Q2d;tder) (View Fentanyl-75 Review and Fentanyl-75 Label ), LYRICA (View Lyrica Review and Lyrica Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), LIPITOR (View Lipitor Review and Lipitor Label ), FLUTICASONE NASAL SPRAY (View Fluticasone Nasal Spray Review and Fluticasone Nasal Spray Label ), DIOVANHCT (VALSARTAN AND HYDROCHLOROTHIAZIDE) (View Diovanhct (valsartan And Hydrochlorothiazide) Review and Diovanhct (valsartan And Hydrochlorothiazide) Label ), LIDODERM PATCHES (LIDOCAINE) (View Lidoderm Patches (lidocaine) Review and Lidoderm Patches (lidocaine) Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ). Patient was hospitalized.

6861141-2 | Pneumonia
on Jul 13, 2010 Female patient from JAPAN , weighting 123.5 lb, was diagnosed with pain (What is pain?), pneumonia (What is pneumonia?), hypertension, post laminectomy syndrome, gastritis and was treated with Fentanyl (View Usage). Patient had the following side effects: pneumonia (What is pneumonia?). Fentanyl dosage: . During the same period patient was treated with DUROTEP MT (View Durotep Mt Review and Durotep Mt Label ), ZOSYN (View Zosyn Review and Zosyn Label ), OLMETEC (View Olmetec Review and Olmetec Label ), RIVOTRIL (View Rivotril Review and Rivotril Label ), TAKEPRON (View Takepron Review and Takepron Label ). Patient was hospitalized.

6860449-4 | Product Adhesion Issue, Product Quality Issue
Patient was taking Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: product adhesion issue, product quality issue on Jul 19, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, weighting 330.0 lb, . Fentanyl dosage: .

6860168-4 | Erythema Multiforme, Product Substitution Issue, Skin Irritation
Adverse event was reported on Jul 19, 2010 by a Male patient taking Fentanyl (View Usage) (Dosage: 100 Mcg Other Top) . Location: UNITED STATES , 57 years of age, Patient experienced the following unwanted or unexpected effects: erythema multiforme, product substitution issue, skin irritation.

6856105-9 | Apnoea, Blood Pressure Decreased, Cardio-respiratory Arrest, Heart Rate Decreased, Respiratory Depression, Somnolence, Unevaluable Event
on Jul 15, 2010 Male patient from UNITED STATES , 79 years of age, weighting 157.9 lb, was diagnosed with surgery (What is surgery?) and was treated with Fentanyl (View Usage). Patient had the following side effects: apnoea, blood pressure decreased, cardio-respiratory arrest, heart rate decreased, respiratory depression, somnolence, unevaluable event. Fentanyl dosage: 25 Mcg Other Iv. During the same period patient was treated with MIDAZOLAM HCL (1 Mg Once Iv) (View Midazolam Hcl Review and Midazolam Hcl Label ).

6855827-3 | Cough, Erythema, Product Label Issue, Pruritus, Respiratory Disorder, Urticaria
on Jul 15, 2010 Female patient from UNITED STATES , 50 years of age, weighting 146.0 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), systemic lupus erythematosus and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: cough, erythema, product label issue, pruritus, respiratory disorder, urticaria. Fentanyl dosage: 50mcg 72 Topical.

6855612-2 | Diabetes Mellitus, Testis Cancer
Patient was taking Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus, testis cancer on Jul 09, 2010 from JAPAN Additional patient health information: Male patient , weighting 132.3 lb, was diagnosed with back pain (What is back pain?), osteoarthritis (What is osteoarthritis?), constipation (What is constipation?), insomnia, hypertension, atrial fibrillation (What is atrial fibrillation?) and. Fentanyl dosage: . During the same period patient was treated with MAGLAX (View Maglax Review and Maglax Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), RENIVACE (View Renivace Review and Renivace Label ), DIGOSIN (View Digosin Review and Digosin Label ). Patient was hospitalized.

6844887-1 | Faecaloma
Adverse event was reported on Jul 02, 2010 by a Male patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma metastatic, gastrointestinal haemorrhage, type 2 diabetes mellitus and. Location: GERMANY , 70 years of age, weighting 136.7 lb, Patient had the following side effects: faecaloma. During the same period patient was treated with PANTOZOL (View Pantozol Review and Pantozol Label ), PANZYTRAT /00014701/ (View Panzytrat /00014701/ Review and Panzytrat /00014701/ Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), URSO FALK (View Urso Falk Review and Urso Falk Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6843462-2 | Agitation, Blood Pressure Increased, Confusional State, Muscle Spasms, Product Quality Issue, Syncope, Withdrawal Syndrome
on Jul 06, 2010 Female patient from UNITED KINGDOM , 78 years of age, was diagnosed with radicular pain and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: agitation, blood pressure increased, confusional state, muscle spasms, product quality issue, syncope, withdrawal syndrome. Fentanyl dosage: . During the same period patient was treated with INDOCIN (View Indocin Review and Indocin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), TRAMADOL (View Tramadol Review and Tramadol Label ). Patient was hospitalized.

6840105-9 | Methaemoglobinaemia
on Jan 22, 2010 Female patient from UNITED KINGDOM , 45 years of age, weighting 94.80 lb, was diagnosed with sedation, local anaesthesia, endocarditis prophylaxis and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: methaemoglobinaemia. Fentanyl dosage: . During the same period patient was treated with ACETAMINOPHEN AND CODEINE PHOSPHATE (View Acetaminophen And Codeine Phosphate Review and Acetaminophen And Codeine Phosphate Label ), OCTAPRESSIN (View Octapressin Review and Octapressin Label ), CITANEST (View Citanest Review and Citanest Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), HYPNOVEL (View Hypnovel Review and Hypnovel Label ), WARFARIN (View Warfarin Review and Warfarin Label ), MIDAZOLAM (View Midazolam Review and Midazolam Label ). Patient was hospitalized.

6835309-5 | Faecaloma
Patient was taking Fentanyl (View Usage). Patient had the following side effects: faecaloma on Jul 05, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, weighting 136.7 lb, was diagnosed with pancreatic carcinoma metastatic, gastrointestinal haemorrhage, diabetes mellitus and. Fentanyl dosage: . During the same period patient was treated with URSO FALK (View Urso Falk Review and Urso Falk Label ), SUCRALFATE (View Sucralfate Review and Sucralfate Label ), INSULIN (View Insulin Review and Insulin Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), PANTOZOL (View Pantozol Review and Pantozol Label ), PANZYTRAT (View Panzytrat Review and Panzytrat Label ). Patient was hospitalized.

6831664-0 | Faecaloma
Adverse event was reported on Jul 02, 2010 by a Male patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with pancreatic carcinoma metastatic and. Location: GERMANY , 70 years of age, weighting 136.7 lb, After Fentanyl was administered, patient had the following side effects: faecaloma. Patient was hospitalized.

6825990-9 | Application Site Erythema, Application Site Rash, Intervertebral Disc Protrusion, Product Adhesion Issue
on Jun 30, 2010 Male patient from UNITED STATES , weighting 189.0 lb, was diagnosed with neuralgia and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: application site erythema, application site rash, intervertebral disc protrusion, product adhesion issue. Fentanyl dosage: Ndc # 0781-7241-55. During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ). Patient was hospitalized.

6825987-9 | Convulsion, Hypotension, Lethargy, Oxygen Saturation Decreased, Respiratory Failure, Troponin Increased
on Jul 02, 2010 Female patient from UNITED STATES , 35 years of age, was treated with Fentanyl (View Usage). Patient had the following side effects: convulsion, hypotension, lethargy, oxygen saturation decreased, respiratory failure, troponin increased. Fentanyl dosage: . During the same period patient was treated with ACETAMINOPHEN AND HYDROCODONE BITARTRATE (2 Tabs) (View Acetaminophen And Hydrocodone Bitartrate Review and Acetaminophen And Hydrocodone Bitartrate Label ). Patient was hospitalized.

6825986-7 | Acute Lung Injury, Hypoxia, Loss Of Consciousness, Troponin Increased
Patient was taking Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: acute lung injury, hypoxia, loss of consciousness, troponin increased on Jul 02, 2010 from UNITED STATES Additional patient health information: Female patient , 34 years of age, . Fentanyl dosage: . During the same period patient was treated with NALOXONE (View Naloxone Review and Naloxone Label ). Patient was hospitalized.

6825985-5 | Loss Of Consciousness, Respiratory Arrest
Adverse event was reported on Jul 02, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: Half Of 100 Ug/hr Patch) . Location: UNITED STATES , 52 years of age, Patient experienced the following unwanted or unexpected effects: loss of consciousness, respiratory arrest. Patient was hospitalized.

6825984-3 | Apnoea, Blood Creatinine Increased, Blood Lactic Acid Increased, Hypoxia, Hypoxic-ischaemic Encephalopathy, Liver Function Test Abnormal, Loss Of Consciousness, Troponin Increased
on Jul 02, 2010 Female patient from UNITED STATES , 51 years of age, was diagnosed with completed suicide and was treated with Fentanyl (View Usage). Patient had the following side effects: apnoea, blood creatinine increased, blood lactic acid increased, hypoxia, hypoxic-ischaemic encephalopathy, liver function test abnormal, loss of consciousness, troponin increased. Fentanyl dosage: .

6822164-2 | Eating Disorder, Feeling Abnormal, Headache, Hypertension, Photopsia, Treatment Noncompliance, Urinary Retention
on Jun 29, 2010 Female patient from UNITED STATES , weighting 146.0 lb, was diagnosed with back pain (What is back pain?), depression (What is depression?), migraine prophylaxis, fibromyalgia, irritable bowel syndrome (What is irritable bowel syndrome?), blood cholesterol, sleep disorder (What is sleep disorder?) and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: eating disorder (What is eating disorder?), feeling abnormal, headache (What is headache?), hypertension, photopsia, treatment noncompliance, urinary retention. Fentanyl dosage: . During the same period patient was treated with CELEXA (View Celexa Review and Celexa Label ), TOPAMAX (View Topamax Review and Topamax Label ), SAVELLA (View Savella Review and Savella Label ), PROTONIX (View Protonix Review and Protonix Label ), LIPITOR (View Lipitor Review and Lipitor Label ), REMERON (View Remeron Review and Remeron Label ), NUCYNTA (View Nucynta Review and Nucynta Label ).

6822159-9 | Oedema Peripheral
Patient was taking Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: oedema peripheral on Jun 29, 2010 from UNITED STATES Additional patient health information: Male patient , 39 years of age, weighting 250.0 lb, was diagnosed with pain in extremity, back pain (What is back pain?) and. Fentanyl dosage: . During the same period patient was treated with DILAUDID (View Dilaudid Review and Dilaudid Label ). Patient was hospitalized.

6822155-1 | Anxiety, Bradycardia, Dyspnoea, Hypertension, Inadequate Analgesia, Nervousness, Renal Pain, Respiratory Distress
Adverse event was reported on Jun 29, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: Ndc#: 0781-7242-55) was diagnosed with osteitis deformans, heart rate irregular, vitamin supplementation, mineral supplementation, hypertension, gastrooesophageal reflux disease and. Location: UNITED STATES , weighting 152.0 lb, Patient had the following side effects: anxiety (What is anxiety?), bradycardia, dyspnoea, hypertension, inadequate analgesia, nervousness, renal pain, respiratory distress. During the same period patient was treated with CARDIZEM (View Cardizem Review and Cardizem Label ), CALCIUM AND VITAMIN D (View Calcium And Vitamin D Review and Calcium And Vitamin D Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NEXIUM (View Nexium Review and Nexium Label ).

6822041-7 | Arthralgia, Arthritis Infective
on Jun 24, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with back pain (What is back pain?), cerebrovascular accident, heart rate irregular and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: arthralgia, arthritis infective. Fentanyl dosage: . During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ), NADOLOL (View Nadolol Review and Nadolol Label ), AMILORIDE HYDROCHLORIDE (View Amiloride Hydrochloride Review and Amiloride Hydrochloride Label ).

6821786-2 | Product Adhesion Issue
on Jul 07, 2010 Male patient from UNITED STATES , 50 years of age, weighting 188.0 lb, was diagnosed with pain (What is pain?), spinal fusion surgery, surgical failure and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: product adhesion issue. Fentanyl dosage: 75 Mcg/h Change 48 Hours Transdermal.

6819066-4 | Bile Duct Cancer, Dysuria
Patient was taking Fentanyl (View Usage). Patient had the following side effects: bile duct cancer, dysuria on Jun 28, 2010 from JAPAN Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with pain (What is pain?), hypertension, gastritis prophylaxis, gastric ulcer, cystitis and. Fentanyl dosage: . During the same period patient was treated with ADALAT CC (View Adalat Cc Review and Adalat Cc Label ), BLOPRESS (View Blopress Review and Blopress Label ), TAKEPRON (View Takepron Review and Takepron Label ), URIEF (View Urief Review and Urief Label ). Patient was hospitalized.

6819062-7 | Dry Skin, Erythema, Product Adhesion Issue
Adverse event was reported on Jun 28, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?) and. Location: UNITED STATES , weighting 95.00 lb, After Fentanyl was administered, patient had the following side effects: dry skin, erythema, product adhesion issue.

6819061-5 | Abdominal Discomfort, Gastrointestinal Disorder
on Jun 28, 2010 Male patient from UNITED STATES , weighting 190.0 lb, was diagnosed with osteoarthritis (What is osteoarthritis?), pain (What is pain?) and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, gastrointestinal disorder. Fentanyl dosage: . During the same period patient was treated with CELEBREX (View Celebrex Review and Celebrex Label ), HYDROCODONE BITARTRATE (10/500 Mg Tablet) (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ).

6819054-8 | Product Adhesion Issue
on Jun 28, 2010 Female patient from UNITED STATES , weighting 167.0 lb, was diagnosed with back disorder, arthritis (What is arthritis?), mineral supplementation and was treated with Fentanyl (View Usage). Patient had the following side effects: product adhesion issue. Fentanyl dosage: . During the same period patient was treated with RELAFEN (View Relafen Review and Relafen Label ), FLEXERIL (View Flexeril Review and Flexeril Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6819053-6 | Product Quality Issue
Patient was taking Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: product quality issue on Jun 28, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 130.0 lb, was diagnosed with pain (What is pain?) and. Fentanyl dosage: . During the same period patient was treated with LORTAB (Dose: 10/500mg) (View Lortab Review and Lortab Label ).

6818768-3 | Cardiac Failure Acute
Adverse event was reported on Jun 22, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with induction of anaesthesia, hypotonia and. Location: UNITED STATES , 19 years of age, weighting 154.3 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure acute. During the same period patient was treated with PROPOFOL (View Propofol Review and Propofol Label ), MIDAZOLAM HCL (View Midazolam Hcl Review and Midazolam Hcl Label ), SEVOFLURANE (View Sevoflurane Review and Sevoflurane Label ), SUCCINYLCHOLINE CHLORIDE (View Succinylcholine Chloride Review and Succinylcholine Chloride Label ).

6817543-3 | Impaired Driving Ability, Overdose, Somnolence, Underdose
on Jun 25, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with pain (What is pain?) and was treated with Fentanyl (View Usage). Patient had the following side effects: impaired driving ability, overdose, somnolence, underdose. Fentanyl dosage: Start Date May-2006.

6816873-9 | Product Quality Issue, Sedation
on Jul 01, 2010 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with pain (What is pain?) and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: product quality issue, sedation. Fentanyl dosage: . During the same period patient was treated with TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ), AMITRIPTYLINE (1/2 At Bedtime) (View Amitriptyline Review and Amitriptyline Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), MORPHINE (View Morphine Review and Morphine Label ), TOPAMAX (View Topamax Review and Topamax Label ), NICOTINE (View Nicotine Review and Nicotine Label ), BUPROPION HCL (View Bupropion Hcl Review and Bupropion Hcl Label ).

6816709-6 | Product Quality Issue
Patient was taking Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: product quality issue on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 139.0 lb, was diagnosed with back pain (What is back pain?) and. Fentanyl dosage: .

6816702-3 | Asthenia, Cold Sweat, Cyst, Influenza Like Illness, Malaise, Pain, Product Adhesion Issue, Withdrawal Syndrome
Adverse event was reported on Jul 01, 2010 by a Female patient taking Fentanyl (View Usage) (Dosage: ) was diagnosed with pain (What is pain?), oesophagitis, depression (What is depression?), anxiety (What is anxiety?) and. Location: UNITED STATES , weighting 200.0 lb, Patient had the following side effects: asthenia, cold sweat, cyst, influenza like illness, malaise, pain (What is pain?), product adhesion issue, withdrawal syndrome. During the same period patient was treated with OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ), EFFEXOR XR (View Effexor Xr Review and Effexor Xr Label ).

6816698-4 | Fall, Flank Pain, Hand Fracture, Nephrolithiasis
on Jun 28, 2010 Male patient from UNITED STATES , weighting 95.00 lb, was diagnosed with raynaud's phenomenon, mixed connective tissue disease, gastrooesophageal reflux disease and was treated with Fentanyl (View Usage). After Fentanyl was administered, patient had the following side effects: fall (What is fall?), flank pain, hand fracture, nephrolithiasis. Fentanyl dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ).

6816696-0 | Inadequate Analgesia, Product Quality Issue, Viral Infection, Withdrawal Syndrome
on Jun 24, 2010 Male patient from UNITED STATES , weighting 255.0 lb, was diagnosed with pain (What is pain?) and was treated with Fentanyl (View Usage). Patient experienced the following unwanted or unexpected effects: inadequate analgesia, product quality issue, viral infection (What is viral infection?), withdrawal syndrome. Fentanyl dosage: . During the same period patient was treated with DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ).

6816682-0 | Product Adhesion Issue
Patient was taking Fentanyl (View Usage). Patient had the following side effects: product adhesion issue on Jun 24, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 115.0 lb, was diagnosed with cancer pain and. Fentanyl dosage: .